Manalo, Arlyn .
HRN: 01-61-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2024
CEFUROXIME 1.5GM (VIAL)
03/30/2024
04/02/2024
IV
1.5g
Q8 X 3 Days
Wbc: 31.9; S/p NSVD With RMLE And Repair
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes